Works matching IS 03405354 AND DT 2001 AND VI 248 AND IP 12


Results: 23
    1
    2
    3

    Efficacy and safety of a standardised 500 unit dose of Dysport<sup>®</sup> (Clostridium botulinum toxin type A haemaglutinin complex) in a heterogeneous cervical dystonia population: results of a prospective, multicentre, randomised, double-blind, placebo-controlled, parallel group study

    Published in:
    Journal of Neurology, 2001, v. 248, n. 12, p. 1073, doi. 10.1007/s004150170028
    By:
    • Wissel, J.;
    • Kanovsky, P.;
    • Ruzicka, E.;
    • Bares, M.;
    • Hortova, H.;
    • Streitova, H.;
    • Jech, R.;
    • Roth, J.;
    • Brenneis, C.;
    • Müller, J.;
    • Schnider, P.;
    • Auff, E.;
    • Richardson, A.;
    • Poewe, W.
    Publication type:
    Article
    4

    Journal Club.

    Published in:
    Journal of Neurology, 2001, v. 248, n. 12, p. 1112, doi. 10.1007/s004150170040
    Publication type:
    Article
    5

    ENS Communications.

    Published in:
    Journal of Neurology, 2001, v. 248, n. 12, p. 1118, doi. 10.1007/s004150170042
    Publication type:
    Article
    6
    7
    8
    9
    10
    11
    12
    13
    14
    15
    16
    17
    19
    20
    21
    22
    23